Filing metadata

Accession number
0001856641-22-000001
Form type
Form 4
Filer
A2A Pharmaceuticals, Inc.
CIK
CIK 1859061
Filed
Jun 28, 2022
Reporting period
Jun 24, 2022
Description
Insider transaction

Explore SEC Filings Hub